SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-21-000066
Filing Date
2021-04-19
Accepted
2021-04-19 06:20:04
Documents
14
Period of Report
2021-04-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20210419.htm   iXBRL 8-K 32036
  Complete submission text file 0001367644-21-000066.txt   180796

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20210419.xsd EX-101.SCH 2484
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20210419_cal.xml EX-101.CAL 764
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20210419_def.xml EX-101.DEF 1710
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20210419_lab.xml EX-101.LAB 25298
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20210419_pre.xml EX-101.PRE 13244
7 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20210419_htm.xml XML 12053
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 21833115
SIC: 2834 Pharmaceutical Preparations